Mr Robert S. George

Tel: 02034566046
Fax: 02034566026

Thoracic surgery

Professional background

Robert George qualified in Medicine from Southampton University in 2000. He completed his basic cardiothoracic training at St Thomas's and Royal Brompton Hospitals. In 2005, he was sponsored by the Magdi Yacoub Institute and the Harefield Heart Science Centre to complete his PhD at Imperial College. During his career he has developed an interest in healthcare management and in 2009 he has completed an MBA in Life Sciences and Healthcare Management.

Robert then undertook his higher surgical training in Thoracic Surgery rotating between Leeds Teaching Hospitals, Sheffield Teaching NHS Trust Hospital and Hull & East Yorkshire NHS Foundation Trust. In October 2016 he joined the thoracic surgery team at Westmoreland Hospital and he has special interest in minimal invasive thoracic surgery, rib fixation, and endobronchial management of airway diseases.

Research interests

Medical Devices
Enhanced Recovery


1) Totally Endoscopic (VATS) First Rib Resection for Thoracic Outlet Syndrome. George RS, Milton R, Chaudhuri N, Kefaloyannis E, Papagiannopoulos K. Annals of Thoracic Surgery 2016

2) A rare case of occult splenic rupture after left pneumonectomy. Acharya MN, George S, Loubani M. Journal of Surgical Case Reports 2016;2016(5)

3) Advances in Chest Drain Management in Thoracic Disease. Robert S. George and Kostas Papagiannopoulos. Journal of Thoracic Disease 2016;8(Suppl 1):S55-S64

4) Lung herniation after uniportal video-assisted thoracic surgery lobectomy presenting with subcutaneous surgical emphysema. Kouritas VK, George RS, Brunelli A, Kefaloyannis E. European Journal of Cardiothoracic Surgery 2016;49(4):1288

5) Vacuum Assisted Closure for Complicated Reconstructions. Robert S. George and Kostas Papagiannopoulos. Current Surgery Reports 2015;3(5), DOI 10.1007/s40137-015-0090-5

6) Novel technique in managing bronchobiliary fistula in adults: Endobronchial embolization using silicone spigots in 2 cases. Kostopanagiotou K, George RS, Kefaloyannis E, Papagiannopoulos K. Annals of Thoracic Medicine 2015;10(1):67-8

7) The expanded role of extracellular matrix patch in malignant and non-malignant chest wall reconstruction in thoracic surgery. George RS, Kostopanagiotou K, Papagiannopoulos K. Interactive Cardiovascular and Thoracic Surgery 2014;18(3):335-9

8) The effect of long-term left ventricular assist device support on myocardial sympathetic activity in patients with non-ischaemic dilated cardiomyopathy. George RS, Birks EJ, Cheetham A, Webb C, Smolenski RT, Khaghani A, Yacoub MH, Kelion A. European Journal of Heart Failure 2013;15(9):1035-43

9) Cardiovascular autonomic control in patients undergoing left ventricular assist device (LVAD) support and pharmacologic therapy. Nunan D, Sandercock GR, George RS, Jakovljevic DG, Donovan G, Bougard R, Yacoub MH, Brodie DA, Birks EJ. International Journal of Cardiology 2013;168(4):4145-9

10) Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention. Marshall A, Cheetham A, George RS, Mason M, Kelion AD. Heart 2012;98(18):1359-65

11) Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation. Birks EJ, George RS, Firouzi A, Wright G, Bahrami T, Yacoub MH, Khaghani A. Journal of Thoracic and Cardiovascular Surgery 2012;144(1):190-6

12) Reversal of Severe Heart Failure Using A Continuous Flow Left Ventricular Assist Device and Pharmacologic Therapy: A Prospective Study. EJ Birks, RS George, M Hedger, T Bahrami, P Wilton, CT Bowles, C Webb, R Bougard, M Amrani, MH Yacoub, G Dreyfus, A Khaghani. Circulation 2011;123(4):381-390

13) Relationship between peak cardiac pumping capability and selected exercise-derived prognostic indicators in patients treated with left ventricular assist devices. Jakovljevic DG, Birks EJ, George RS, Trenell MI, Seferovic PM, Yacoub MH, Brodie DA. European Journal of Heart Failure 2011;13(9):992-9

14) Innominate truncal dissection and rupture into right pleural cavity following acute type A dissection of the aorta with right coronary ostial avulsion and inferior STEMI. Kaul P, George R, Paniagua R, Petsa A, Congiu S. Perfusion 2011;26(5):435-40

15) Molecular changes occurring during reverse remodelling following left ventricular assist device support. Birk EJ, George RS. Journal of Cardiovascular Translational Research 2010;3(6):635-42

16) Echocardiographic assessment of flow across continuous flow ventricular assist devices at low speeds. RS George, NK Sabharwal, C Webb, MH Yacoub, CT Bowles, M Hedger, A Khaghani, EJ Birks. Journal of Heart and Lung Transplantation 2010;29(11):1245-52

17) The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance. Jakovljevic DG, George RS, Nunan D, Donovan G, Bougard RS, Yacoub MH, Birks EJ, Brodie DA. Heart 2010;96(17):1390-5

18) Comparison of cardiac power output and exercise performance in patients with left ventricular assist devices, explanted (recovered) patients, and those with moderate to severe heart failure. Jakovljevic DG, George RS, Donovan G, Nunan D, Henderson K, Bougard RS, Yacoub MH, Birks EJ, Brodie DA. American Journal of Cardiology 2010;105(12):1780-5

19) Sustained myocardial recovery 5 years after in situ disconnection of a Jarvik 2000 device. George RS, Khaghani C, Bowles CT, Khaghani A, Birks EJ. Journal of Heart and Lung Transplantation 2010;29(5):587-8

20) Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. El-Hamamsy I, Eryigit Z, Stevens LM, Sarang Z, George R, Clark L, Melina G, Takkenberg JJ, Yacoub MH. Lancet 2010;376(9470):524-531

21) The Left Ventricular Outflow Tract in Hypertrophic Cardiomyopathy: From Structure to Function. MH Yacoub, I El-Hamamsy, KSaid, G Magdi, F Abul Enein, R George, A Rossi, I Olivotto, F Cecchi. Journal of Cardiovascular Translational Research 2009;2(4):510-517

22) Expression of extracellular matrix genes during myocardial recovery from heart failure following left ventricular assist Device (LVAD) Support. LE Felkin, E Lara-Pezzi, R George, MH Yacoub, EJ Birks, PJR Barton. Journal of Heart and Lung Transplantation 2009;28(2):117-122

23) Quality of life after removal of left ventricular assist device for myocardial recovery. George RS, Yacoub MH, Bowles CT, Hipkin M, Rogers P, Hallas C, Banner NR, Dreyfus G, Khaghani A, Birks EJ. Journal of Heart and Lung Transplantation 2008;27(2):165-72

24) Hemodynamic and echocardiographic responses to acute interruption of left ventricular assist device support: relevance to assessment of myocardial recovery. George RS, Yacoub MH, Tasca G, Webb C, Bowles CT, Tansley P, Hardy JP, Dreyfus G, Khaghani A, Birks EJ. Journal of Heart and Lung Transplantation 2007;26(10):967-73

25) Expression of follistatin-related genes is altered in heart failure. E Lara-Pezzi, L Felkin, EJ Birks, P Sarathchandra, KD Panse, R George, JL Hall, MH Yacoub, N Rosenthal, PJR Barton. Endocrinology 2008;149:5822-27

26) Bridge to transplantation with a left ventricular assist device for systemic ventricular failure after Mustard procedure. George RS, Birks EJ, Radley-Smith RC, Khaghani A, Yacoub M. Annals of Thoracic Surgery 2007;83(1):306-8

27) Changes in Sarcomeric, Non-Sarcomeric Proteins and Focal Adhesion Molecules During Clinical Myocardial Recovery Following Left Ventricular Assist Device Support. N Latif, M Yacoub, RS George, P Barton, EJ Birks. Journal of Heart and Lung Transplantation 2007;26(3):230-5

28) Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Hall JL, Birks EJ, Grindle S, Cullen ME, Barton PJ, Rider JE, Lee S, Harwalker S, Mariash A, Adhikari N, Charles NJ, Felkin LE, Polster S, George RS, Miller LW, Yacoub MH. European Heart Journal 2007;28(5):613-27

29) Correlation between vascular responsivensss and expression of novel transcripts of the ETA-receptor in human vascular tissue. Chester AH, Azam R, Felkin LE, George R, Brand N. Vascular Pharmacology 2007;46(3):181-7

30) Left ventricular assist device and drug therapy for the reversal of heart failure. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. New England Journal of Medicine 2006;355(18):1873-84

31) Acinetobacter mediastinitis in a heart transplant patient. George RS, Birks EJ, Haj-Yahia S, Bowles CT, Hall A, Khaghani A, Petrou M. Annals of Thoracic Surgery 2006;82(2):715-6

GMC/GDC number: 4717858